Abstract
Protein phosphatase 2A (PP2A) is a ubiquitous multifunctional enzyme usually known as a tumor suppressor. Recent studies have reported that although inhibition of PP2A leads to acceleration of cell growth, it also induces damaged cells to pass through the cell cycle and renders them sensitive to radiotherapy. Here, we investigated the radiosensitizing effects of digoxin as a PP2A inhibitor in two non-small-cell lung cancer (NSCLC) cell types (H460 and A549) with differential sensitivity to radiation. Digoxin inhibited the proliferation of H460 and A549 cells in a dose-dependent fashion and was especially effective on radioresistant A549 cells. Interestingly, the radiosensitizing effect of digoxin was only present in the radioresistant A549 cells and xenografts. The combination of digoxin and ionizing radiation (IR) significantly reduced clonogenic survival and xenograft tumor growth (P<0.001), compared with IR alone. Digoxin suppressed PP2A protein expression and prevented IR-induced PP2A expression in A549 cells. Digoxin treatment combined with IR allowed the damaged cell to progress through the cell cycle via suppression of cell cycle-related proteins (p53, cyclin D1, cyclin B1, CDK4, and p-cdc2). Moreover, digoxin enhanced I...Continue Reading
References
Jan 1, 1977·Clinical Pharmacokinetics·E Iisalo
Jul 4, 1998·Radiation Oncology Investigations·F Verheye-Dua, L Böhm
Jul 13, 2001·Cancer Letters·A H Schönthal
Aug 10, 2002·Cancer Letters·Sachiko NasuRobert Newman
Oct 29, 2004·The EMBO Journal·Aaron A GoodarziKum Kum Khanna
Nov 29, 2005·Molecular Cell·Dipanjan ChowdhuryJudy Lieberman
Mar 12, 2008·Molecular Interventions·Robert A NewmanKeith I Block
Nov 21, 2008·Proceedings of the National Academy of Sciences of the United States of America·Huafeng ZhangGregg L Semenza
Jan 14, 2009·Molecular Cancer Therapeutics·Jun MiJames M Larner
Apr 21, 2009·Nature Cell Biology·Joanne ChewVinay Tergaonkar
Dec 18, 2009·Cell Cycle·Agatha SusilaCheng-Gee Koh
Oct 12, 2010·Journal of Oncology·Nathan Moore, Stephen Lyle
Oct 1, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Wei LiZe-Kuan Xu
Oct 11, 2011·Bioscience Reports·Gautam SethiVinay Tergaonkar
Nov 1, 2011·Toxicology and Applied Pharmacology·Hosam A ElbazYon Rojanasakul
Mar 5, 2013·Cancer Letters·Parthasarathy SeshacharyuluSurinder K Batra
Mar 19, 2014·Biochemical Pharmacology·Annalisa TrentiLucia Trevisi
Mar 6, 2015·Clinical and Experimental Pharmacology & Physiology·Cameron T DurlacherShu-Feng Zhou
Apr 22, 2015·Cancer Biology & Therapy·Christopher S HongZhengping Zhuang
May 6, 2015·Molecular Cancer Therapeutics·Ira K GordonZhengping Zhuang
May 6, 2015·The Biochemical Journal·Edna Zhi Pei ChaiGautam Sethi
May 7, 2015·Oncotarget·Hao LiuZhimin He
May 9, 2015·PloS One·Sheng-Yi LinJeremy J W Chen
Jan 15, 2016·CA: a Cancer Journal for Clinicians·Lindsey A TorreRebecca L Siegel
Jul 20, 2016·Scientific Reports·Nayoung KimSukjoon Yoon
Jul 28, 2016·PloS One·Miao LiuXuan Liu
Jan 6, 2017·Laboratory animal research·Ji Young LeeYoun Kyoung Jeong
Apr 30, 2017·Journal of Thoracic Disease·Guang-Zong ChenXin-Chen Sun